| answer text |
<p>HIV pre-exposure prophylaxis (PrEP) is currently available through the three year,
NHS England funded, PrEP impact trial, which is providing HIV prevention drugs to
people at high risk of HIV infection. Expansion of the trial is underway across the
country following the my Rt. hon. Friend Secretary of State for Health and Social
Care’s announcement in January that the trial would be expanded to 26,000 people.
Participation in the trial is on a voluntary basis and it is for local authorities
to decide whether they wish to take part. Work is now starting to consider future
commissioning for PrEP after the trial has ended.</p>
|
 |
